129 related articles for article (PubMed ID: 38806096)
1. Controlled release of vitamin A palmitate from crosslinked cyclodextrin organic framework for dry eye disease therapy.
Ye X; Li F; Li M; Zhang G; Wang W; Wang Z; Zhang H; Dong L; Lin X; Wu L; Peng C; Wang L; Chen W; Zhang J
Int J Pharm; 2024 Jun; 659():124279. PubMed ID: 38806096
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels.
He W; Guo X; Feng M; Mao N
Int J Pharm; 2013 Dec; 458(2):305-14. PubMed ID: 24409520
[TBL] [Abstract][Full Text] [Related]
3. Prolonged Release Niosomes For Ocular Delivery of Loteprednol: Ocular Distribution Assessment on Dry Eye Disease Induced Rabbit Model.
Ozdemir S; Uner B
AAPS PharmSciTech; 2024 May; 25(5):119. PubMed ID: 38816667
[TBL] [Abstract][Full Text] [Related]
4. [Preparation and in vitro corneal retention behavior of novel cationic microemulsion/in situ gel system].
Ma SW; Gan Y; Gan L; Zhu CL; Zhu JB
Yao Xue Xue Bao; 2008 Jul; 43(7):749-55. PubMed ID: 18819481
[TBL] [Abstract][Full Text] [Related]
5. Long-acting mucoadhesive thermogels for improving topical treatments of dry eye disease.
Luo LJ; Nguyen DD; Lai JY
Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111095. PubMed ID: 32600699
[TBL] [Abstract][Full Text] [Related]
6. Temperature sensitive contact lenses for triggered ophthalmic drug delivery.
Jung HJ; Chauhan A
Biomaterials; 2012 Mar; 33(7):2289-300. PubMed ID: 22182750
[TBL] [Abstract][Full Text] [Related]
7. Enhanced stability of vitamin A palmitate microencapsulated by γ-cyclodextrin metal-organic frameworks.
Zhang G; Meng F; Guo Z; Guo T; Peng H; Xiao J; Liu B; Singh V; Gui S; York P; Qian W; Wu L; Zhang J
J Microencapsul; 2018 May; 35(3):249-258. PubMed ID: 29624456
[TBL] [Abstract][Full Text] [Related]
8. Solvent-Free Loading of Vitamin A Palmitate into β-Cyclodextrin Metal-Organic Frameworks for Stability Enhancement.
Zhang Y; Chen J; Zhang Z; Zhu H; Ma W; Zhao X; Wang M; Wang C; Chen W; Naeem A; Zhang J; Guo T; Wu L
AAPS PharmSciTech; 2023 Jun; 24(5):136. PubMed ID: 37308749
[TBL] [Abstract][Full Text] [Related]
9. Comparison of thermosensitive in situ gels and drug-resin complex for ocular drug delivery: In vitro drug release and in vivo tissue distribution.
Wei Y; Li C; Zhu Q; Zhang X; Guan J; Mao S
Int J Pharm; 2020 Mar; 578():119184. PubMed ID: 32112932
[TBL] [Abstract][Full Text] [Related]
10. Novel nanostructured lipid carriers loading Apigenin for anterior segment ocular pathologies.
Bonilla-Vidal L; Espina M; García ML; Baldomà L; Badia J; González JA; Delgado LM; Gliszczyńska A; Souto EB; Sánchez-López E
Int J Pharm; 2024 Jun; 658():124222. PubMed ID: 38735632
[TBL] [Abstract][Full Text] [Related]
11. Phenylboronic acid-tethered chondroitin sulfate-based mucoadhesive nanostructured lipid carriers for the treatment of dry eye syndrome.
Tan G; Li J; Song Y; Yu Y; Liu D; Pan W
Acta Biomater; 2019 Nov; 99():350-362. PubMed ID: 31449929
[TBL] [Abstract][Full Text] [Related]
12. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.
Li J; Tan G; Cheng B; Liu D; Pan W
Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370
[TBL] [Abstract][Full Text] [Related]
13. A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome.
Kim EC; Choi JS; Joo CK
Am J Ophthalmol; 2009 Feb; 147(2):206-213.e3. PubMed ID: 18848318
[TBL] [Abstract][Full Text] [Related]
14. Gel in core carbosomes as novel ophthalmic vehicles with enhanced corneal permeation and residence.
Moustafa MA; El-Refaie WM; Elnaggar YSR; Abdallah OY
Int J Pharm; 2018 Jul; 546(1-2):166-175. PubMed ID: 29778824
[TBL] [Abstract][Full Text] [Related]
15. Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.
Mandal A; Bisht R; Rupenthal ID; Mitra AK
J Control Release; 2017 Feb; 248():96-116. PubMed ID: 28087407
[TBL] [Abstract][Full Text] [Related]
16. Silk Fibroin Formed Bioadhesive Ophthalmic Gel for Dry Eye Syndrome Treatment.
Hao T; Tang L; Xu Q; Wang W; Li Z; Shen Y; Xu B; Luo H; Li Q; Wang J; Zhang J
AAPS PharmSciTech; 2024 Apr; 25(5):92. PubMed ID: 38684590
[TBL] [Abstract][Full Text] [Related]
17. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Mahmoud AA; El-Feky GS; Kamel R; Awad GE
Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
[TBL] [Abstract][Full Text] [Related]
18. Gelatin-epigallocatechin gallate nanoparticles with hyaluronic acid decoration as eye drops can treat rabbit dry-eye syndrome effectively via inflammatory relief.
Huang HY; Wang MC; Chen ZY; Chiu WY; Chen KH; Lin IC; Yang WV; Wu CC; Tseng CL
Int J Nanomedicine; 2018; 13():7251-7273. PubMed ID: 30510416
[TBL] [Abstract][Full Text] [Related]
19. Latanoprost-loaded cyclodextrin microaggregate suspension eye drops for enhanced bioavailability and stability.
Zhou X; Li X; Xu J; Cheng Y; Cao F
Eur J Pharm Sci; 2021 May; 160():105758. PubMed ID: 33588044
[TBL] [Abstract][Full Text] [Related]
20. Impact of Nanostructured Lipid Carriers as an Artificial Tear Film in a Rabbit Evaporative Dry Eye Model.
Niamprem P; Teapavarapruk P; Srinivas SP; Tiyaboonchai W
Cornea; 2019 Apr; 38(4):485-491. PubMed ID: 30681516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
